{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:40:39Z","timestamp":1788932439947,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,10]]},"DOI":"10.7759\/cureus.92020","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:21:14Z","timestamp":1757568074000},"source":"Crossref","is-referenced-by-count":1,"title":["Gut Microbiota Modulation in Type 2 Diabetes and Cardiometabolic Risk: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Umer","family":"Qureshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohaib","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abena","family":"Aggrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama Hassan","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qurrat","family":"Ul Ain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-062218-023720","article-title":"A crucial role for diet in the relationship between gut microbiota and cardiometabolic disease","volume":"71","author":"Attaye I","year":"2020","unstructured":"Attaye I, Pinto-Sietsma SJ, Herrema H, Nieuwdorp M. A crucial role for diet in the relationship between gut microbiota and cardiometabolic disease. Annu Rev Med. 2020, 71:149-61. 10.1146\/annurev-med-062218-023720","journal-title":"Annu Rev Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40519-018-0481-6","article-title":"Insulin resistance in obesity: an overview of fundamental alterations","volume":"23","author":"Barazzoni R","year":"2018","unstructured":"Barazzoni R, Gortan Cappellari G, Ragni M, Nisoli E. Insulin resistance in obesity: an overview of fundamental alterations. Eat Weight Disord. 2018, 23:149-57. 10.1007\/s40519-018-0481-6","journal-title":"Eat Weight Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s13668-024-00541-z","article-title":"Dietary modulations in preventing cardiometabolic risk in individuals with type 2 diabetes","volume":"13","author":"Dal N","year":"2024","unstructured":"Dal N, Bilici S. Dietary modulations in preventing cardiometabolic risk in individuals with type 2 diabetes. Curr Nutr Rep. 2024, 13:412-21. 10.1007\/s13668-024-00541-z","journal-title":"Curr Nutr Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1149256","article-title":"Pharmacomicrobiomics and type 2 diabetes mellitus: a novel perspective towards possible treatment","volume":"14","author":"Jia L","year":"2023","unstructured":"Jia L, Huang S, Sun B, Shang Y, Zhu C. Pharmacomicrobiomics and type 2 diabetes mellitus: a novel perspective towards possible treatment. Front Endocrinol (Lausanne). 2023, 14:1149256. 10.3389\/fendo.2023.1149256","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5205126","article-title":"Implications of the intestinal microbiota in diagnosing the progression of diabetes and the presence of cardiovascular complications","volume":"2018","author":"Leustean AM","year":"2018","unstructured":"Leustean AM, Ciocoiu M, Sava A, Costea CF, Floria M, Tarniceriu CC, Tanase DM. Implications of the intestinal microbiota in diagnosing the progression of diabetes and the presence of cardiovascular complications. J Diabetes Res. 2018, 2018:5205126. 10.1155\/2018\/5205126","journal-title":"J Diabetes Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2022.08.018","article-title":"Modulatory role of gut microbiota in cholesterol and glucose metabolism: Potential implications for atherosclerotic cardiovascular disease","volume":"359","author":"Roessler J","year":"2022","unstructured":"Roessler J, Leistner DM, Landmesser U, Haghikia A. Modulatory role of gut microbiota in cholesterol and glucose metabolism: Potential implications for atherosclerotic cardiovascular disease. Atherosclerosis. 2022, 359:1-12. 10.1016\/j.atherosclerosis.2022.08.018","journal-title":"Atherosclerosis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108457","article-title":"Bile acid metabolism and signaling: emerging pharmacological targets of dietary polyphenols","volume":"248","author":"Tveter KM","year":"2023","unstructured":"Tveter KM, Mezhibovsky E, Wu Y, Roopchand DE. Bile acid metabolism and signaling: emerging pharmacological targets of dietary polyphenols. Pharmacol Ther. 2023, 248:108457. 10.1016\/j.pharmthera.2023.108457","journal-title":"Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/17446651.2020.1720511","article-title":"Gut microbiota: a promising target against cardiometabolic diseases","volume":"15","author":"Warmbrunn MV","year":"2020","unstructured":"Warmbrunn MV, Herrema H, Aron-Wisnewsky J, Soeters MR, Van Raalte DH, Nieuwdorp M. Gut microbiota: a promising target against cardiometabolic diseases. Expert Rev Endocrinol Metab. 2020, 15:13-27. 10.1080\/17446651.2020.1720511","journal-title":"Expert Rev Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1017\/S0029665120000117","article-title":"Current metabolic perspective on malnutrition in obesity: towards more subgroup-based nutritional approaches?","volume":"79","author":"Blaak EE","year":"2020","unstructured":"Blaak EE. Current metabolic perspective on malnutrition in obesity: towards more subgroup-based nutritional approaches?. Proc Nutr Soc. 2020, 79:331-7. 10.1017\/S0029665120000117","journal-title":"Proc Nutr Soc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-019-4791-x","article-title":"Microbiome, diabetes and heart: a\u00a0novel link?","volume":"44","author":"Kappel BA","year":"2019","unstructured":"Kappel BA, Lehrke M. Microbiome, diabetes and heart: a\u00a0novel link?. Herz. 2019, 44:223-30. 10.1007\/s00059-019-4791-x","journal-title":"Herz"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2015.10.012","article-title":"The effect of prebiotic supplementation with inulin on cardiometabolic health: Rationale, design, and methods of a controlled feeding efficacy trial in adults at risk of type 2 diabetes","volume":"45","author":"Mitchell CM","year":"2015","unstructured":"Mitchell CM, Davy BM, Halliday TM, Hulver MW, Neilson AP, Ponder MA, Davy KP. The effect of prebiotic supplementation with inulin on cardiometabolic health: Rationale, design, and methods of a controlled feeding efficacy trial in adults at risk of type 2 diabetes. Contemp Clin Trials. 2015, 45:328-37. 10.1016\/j.cct.2015.10.012","journal-title":"Contemp Clin Trials"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-020-00603-6","article-title":"Probiotics supplementation and insulin resistance: a systematic review","volume":"12","author":"Salles BI","year":"2020","unstructured":"Salles BI, Cioffi D, Ferreira SR. Probiotics supplementation and insulin resistance: a systematic review. Diabetol Metab Syndr. 2020, 12:98. 10.1186\/s13098-020-00603-6","journal-title":"Diabetol Metab Syndr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-01007-5","article-title":"Population study of the gut microbiome: associations with diet, lifestyle, and cardiometabolic disease","volume":"13","author":"Walker RL","year":"2021","unstructured":"Walker RL, Vlamakis H, Lee JW, et al.. Population study of the gut microbiome: associations with diet, lifestyle, and cardiometabolic disease. Genome Med. 2021, 13:188. 10.1186\/s13073-021-01007-5","journal-title":"Genome Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement","volume":"134","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021, 134:103-12. 10.1016\/j.jclinepi.2021.02.003","journal-title":"J Clin Epidemiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5195\/jmla.2020.739","article-title":"A comparison of patient, intervention, comparison, outcome (PICO) to a new, alternative clinical question framework for search skills, search results, and self-efficacy: a randomized controlled trial","volume":"108","author":"Kloda LA","year":"2020","unstructured":"Kloda LA, Boruff JT, Cavalcante AS. A comparison of patient, intervention, comparison, outcome (PICO) to a new, alternative clinical question framework for search skills, search results, and self-efficacy: a randomized controlled trial. J Med Libr Assoc. 2020, 108:185-94. 10.5195\/jmla.2020.739","journal-title":"J Med Libr Assoc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010606","article-title":"Conflicts of interest and spin in reviews of psychological therapies: a systematic review","volume":"6","author":"Lieb K","year":"2016","unstructured":"Lieb K, von der Osten-Sacken J, Stoffers-Winterling J, Reiss N, Barth J. Conflicts of interest and spin in reviews of psychological therapies: a systematic review. BMJ Open. 2016, 6:e010606. 10.1136\/bmjopen-2015-010606","journal-title":"BMJ Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.01.006","article-title":"Applying Grading of Recommendations Assessment, Development and Evaluation (GRADE) to diagnostic tests was challenging but doable","volume":"67","author":"Gopalakrishna G","year":"2014","unstructured":"Gopalakrishna G, Mustafa RA, Davenport C, et al.. Applying Grading of Recommendations Assessment, Development and Evaluation (GRADE) to diagnostic tests was challenging but doable. J Clin Epidemiol. 2014, 67:760-8. 10.1016\/j.jclinepi.2014.01.006","journal-title":"J Clin Epidemiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-5583-7_311","article-title":"Thematic analysis","volume":"12","author":"Clarke V","year":"2017","unstructured":"Clarke V, Braun V. Thematic analysis. J Posit Psychol. 2017, 12:297-8. 10.1007\/978-1-4614-5583-7_311","journal-title":"J Posit Psychol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/alr.20095","article-title":"Development of an evidence-based review with recommendations using an online iterative process","volume":"1","author":"Rudmik L","year":"2011","unstructured":"Rudmik L, Smith TL. Development of an evidence-based review with recommendations using an online iterative process. Int Forum Allergy Rhinol. 2011, 1:431-7. 10.1002\/alr.20095","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2015.11.011","article-title":"Clinical application of probiotics in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study","volume":"36","author":"Tonucci LB","year":"2017","unstructured":"Tonucci LB, Olbrich Dos Santos KM, Licursi de Oliveira L, Rocha Ribeiro SM, Duarte Martino HS. Clinical application of probiotics in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study. Clin Nutr. 2017, 36:85-92. 10.1016\/j.clnu.2015.11.011","journal-title":"Clin Nutr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3168\/jds.2010-4128","article-title":"Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus","volume":"94","author":"Ejtahed HS","year":"2011","unstructured":"Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V, Akbarian-Moghari A. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci. 2011, 94:3288-94. 10.3168\/jds.2010-4128","journal-title":"J Dairy Sci"},{"key":"ref22","article-title":"Short-term consumption of probiotic yogurt improved HDL-C of type 2 diabetes mellitus patients","volume":"26","author":"Lestari LA","year":"2019","unstructured":"Lestari LA, Ratnasari D, Azizah EF, et al.. Short-term consumption of probiotic yogurt improved HDL-C of type 2 diabetes mellitus patients. Rom J Diabetes Nutr Metab Dis. 2019, 26:381-92.","journal-title":"Rom J Diabetes Nutr Metab Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes","volume":"359","author":"Zhao L","year":"2018","unstructured":"Zhao L, Zhang F, Ding X, et al.. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018, 359:1151-6. 10.1126\/science.aao5774","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1069954","article-title":"High-fiber diet ameliorates gut microbiota, serum metabolism and emotional mood in type 2 diabetes patients","volume":"13","author":"Chen L","year":"2023","unstructured":"Chen L, Liu B, Ren L, et al.. High-fiber diet ameliorates gut microbiota, serum metabolism and emotional mood in type 2 diabetes patients. Front Cell Infect Microbiol. 2023, 13:1069954. 10.3389\/fcimb.2023.1069954","journal-title":"Front Cell Infect Microbiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317609","article-title":"Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial","volume":"68","author":"Wan Y","year":"2019","unstructured":"Wan Y, Wang F, Yuan J, et al.. Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial. Gut. 2019, 68:1417-29. 10.1136\/gutjnl-2018-317609","journal-title":"Gut"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1897217","article-title":"Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome","volume":"13","author":"Manrique P","year":"2021","unstructured":"Manrique P, Zhu Y, van der Oost J, Herrema H, Nieuwdorp M, de Vos WM, Young M. Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome. Gut Microbes. 2021, 13:1-15. 10.1080\/19490976.2021.1897217","journal-title":"Gut Microbes"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/nu16203491","article-title":"Microbiota transplantation in individuals with type 2 diabetes and a high degree of insulin resistance","volume":"16","author":"G\u00f3mez-P\u00e9rez AM","year":"2024","unstructured":"G\u00f3mez-P\u00e9rez AM, Mu\u00f1oz-Garach A, Lasserrot-Cuadrado A, Moreno-Indias I, Tinahones FJ. Microbiota transplantation in individuals with type 2 diabetes and a high degree of insulin resistance. Nutrients. 2024, 16:3491. 10.3390\/nu16203491","journal-title":"Nutrients"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/foods9091279","article-title":"Modifications of gut microbiota after grape pomace supplementation in subjects at cardiometabolic risk: a randomized cross-over controlled clinical trial","volume":"9","author":"Ramos-Romero S","year":"2020","unstructured":"Ramos-Romero S, Mart\u00ednez-Maqueda D, Hereu M, Am\u00e9zqueta S, Torres JL, P\u00e9rez-Jim\u00e9nez J. Modifications of gut microbiota after grape pomace supplementation in subjects at cardiometabolic risk: a randomized cross-over controlled clinical trial. Foods. 2020, 9:1279. 10.3390\/foods9091279","journal-title":"Foods"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.691564","article-title":"Dietary interventions reduce traditional and novel cardiovascular risk markers by altering the gut microbiome and their metabolites","volume":"8","author":"Vijay A","year":"2021","unstructured":"Vijay A, Astbury S, Panayiotis L, Marques FZ, Spector TD, Menni C, Valdes AM. Dietary interventions reduce traditional and novel cardiovascular risk markers by altering the gut microbiome and their metabolites. Front Cardiovasc Med. 2021, 8:691564. 10.3389\/fcvm.2021.691564","journal-title":"Front Cardiovasc Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01015-z","article-title":"The effects of the Green-Mediterranean diet on cardiometabolic health are linked to gut microbiome modifications: a randomized controlled trial","volume":"14","author":"Rinott E","year":"2022","unstructured":"Rinott E, Meir AY, Tsaban G, et al.. The effects of the Green-Mediterranean diet on cardiometabolic health are linked to gut microbiome modifications: a randomized controlled trial. Genome Med. 2022, 14:29. 10.1186\/s13073-022-01015-z","journal-title":"Genome Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2426610","article-title":"Gut microbial metabolism of bile acids modifies the effect of Mediterranean diet interventions on cardiometabolic risk in a randomized controlled trial","volume":"16","author":"Gao P","year":"2024","unstructured":"Gao P, Rinott E, Dong D, et al.. Gut microbial metabolism of bile acids modifies the effect of Mediterranean diet interventions on cardiometabolic risk in a randomized controlled trial. Gut Microbes. 2024, 16:2426610. 10.1080\/19490976.2024.2426610","journal-title":"Gut Microbes"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103459","article-title":"A six-day, lifestyle-based immersion program mitigates cardiovascular risk factors and induces shifts in gut microbiota, specifically Lachnospiraceae, Ruminococcaceae, Faecalibacterium prausnitzii: a pilot study","volume":"13","author":"Ahrens AP","year":"2021","unstructured":"Ahrens AP, Culpepper T, Saldivar B, et al.. A six-day, lifestyle-based immersion program mitigates cardiovascular risk factors and induces shifts in gut microbiota, specifically Lachnospiraceae, Ruminococcaceae, Faecalibacterium prausnitzii: a pilot study. Nutrients. 2021, 13:3459. 10.3390\/nu13103459","journal-title":"Nutrients"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12920-z","article-title":"Chitin-glucan supplementation improved postprandial metabolism and altered gut microbiota in subjects at cardiometabolic risk in a randomized trial","volume":"12","author":"Ranaivo H","year":"2022","unstructured":"Ranaivo H, Zhang Z, Alligier M, et al.. Chitin-glucan supplementation improved postprandial metabolism and altered gut microbiota in subjects at cardiometabolic risk in a randomized trial. Sci Rep. 2022, 12:8830. 10.1038\/s41598-022-12920-z","journal-title":"Sci Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016518","article-title":"Effects of a vegetarian diet on cardiometabolic risk factors, gut microbiota, and plasma metabolome in subjects with ischemic heart disease: a randomized, crossover study","volume":"9","author":"Djekic D","year":"2020","unstructured":"Djekic D, Shi L, Brolin H, et al.. Effects of a vegetarian diet on cardiometabolic risk factors, gut microbiota, and plasma metabolome in subjects with ischemic heart disease: a randomized, crossover study. J Am Heart Assoc. 2020, 9:e016518. 10.1161\/JAHA.120.016518","journal-title":"J Am Heart Assoc"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2014.177","article-title":"Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula","volume":"9","author":"Xu J","year":"2015","unstructured":"Xu J, Lian F, Zhao L, et al.. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. ISME J. 2015, 9:552-62. 10.1038\/ismej.2014.177","journal-title":"ISME J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung M","year":"2020","unstructured":"Gurung M, Li Z, You H, Rodrigues R, Jump DB, Morgun A, Shulzhenko N. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020, 51:102590. 10.1016\/j.ebiom.2019.11.051","journal-title":"EBioMedicine"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.632335","article-title":"Modulating the microbiota as a therapeutic intervention for type 2 diabetes","volume":"12","author":"Huda MN","year":"2021","unstructured":"Huda MN, Kim M, Bennett BJ. Modulating the microbiota as a therapeutic intervention for type 2 diabetes. Front Endocrinol (Lausanne). 2021, 12:632335. 10.3389\/fendo.2021.632335","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113148","article-title":"Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes","volume":"152","author":"Sharma BR","year":"2022","unstructured":"Sharma BR, Jaiswal S, Ravindra PV. Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes. Biomed Pharmacother. 2022, 152:113148. 10.1016\/j.biopha.2022.113148","journal-title":"Biomed Pharmacother"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.endoen.2016.07.004","article-title":"Gut microbiota and type 2 diabetes mellitus","volume":"63","author":"Munoz-Garach A","year":"2016","unstructured":"Munoz-Garach A, Diaz-Perdigones C, Tinahones FJ. Gut microbiota and type 2 diabetes mellitus. Endocrinol Nutr. 2016, 63:560-8. 10.1016\/j.endoen.2016.07.004","journal-title":"Endocrinol Nutr"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2018.1536646","article-title":"Dietary compounds and traditional Chinese medicine ameliorate type 2 diabetes by modulating gut microbiota","volume":"59","author":"Nie Q","year":"2019","unstructured":"Nie Q, Chen H, Hu J, Fan S, Nie S. Dietary compounds and traditional Chinese medicine ameliorate type 2 diabetes by modulating gut microbiota. Crit Rev Food Sci Nutr. 2019, 59:848-63. 10.1080\/10408398.2018.1536646","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2024.05.017","article-title":"Exploring the relationship between gut microbiome modulation and blood pressure in type 2 diabetes: an umbrella review","volume":"34","author":"Amini-Salehi E","year":"2024","unstructured":"Amini-Salehi E, Mahapatro A, Korsapati RR, et al.. Exploring the relationship between gut microbiome modulation and blood pressure in type 2 diabetes: an umbrella review. Nutr Metab Cardiovasc Dis. 2024, 34:2046-54. 10.1016\/j.numecd.2024.05.017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0874","article-title":"Mechanisms in endocrinology: gut microbiota in patients with type 2 diabetes mellitus","volume":"172","author":"Allin KH","year":"2015","unstructured":"Allin KH, Nielsen T, Pedersen O. Mechanisms in endocrinology: gut microbiota in patients with type 2 diabetes mellitus. Eur J Endocrinol. 2015, 172:R167-77. 10.1530\/EJE-14-0874","journal-title":"Eur J Endocrinol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-019-10156-y","article-title":"Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus","volume":"103","author":"Salga\u00e7o MK","year":"2019","unstructured":"Salga\u00e7o MK, Oliveira LG, Costa GN, Bianchi F, Sivieri K. Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus. Appl Microbiol Biotechnol. 2019, 103:9229-38. 10.1007\/s00253-019-10156-y","journal-title":"Appl Microbiol Biotechnol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/402948-gut-microbiota-modulation-in-type-2-diabetes-and-cardiometabolic-risk-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:21:15Z","timestamp":1757568075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/402948-gut-microbiota-modulation-in-type-2-diabetes-and-cardiometabolic-risk-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.92020","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,10]]}}}